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Abstract
Background: Gestational Diabetes (GDM) can have adverse effects on the health of both
mother and baby during pregnancy and for a lifetime thereafter. While insulin is the mainstay of
treatment, metformin and glyburide may be considered as alternatives (Carroll & Kelley, 2014).
Pregnant mothers, however, may be hesitant to use pharmaceutical therapies, preferring natural
alternatives (Zaki & Albarraq, 2014).
Purpose: The purpose of this paper is to identify and examine effective non-pharmacological
interventions for the prevention and the management of GDM.
Results: Twenty-one articles were included in this review and thirteen studies support the use of
certain diets (Mediterranean or Dash diets), and dietary supplements (myo-inositol, probiotics,
and vitamin D supplementation) in the prevention and management of GDM. The other eight
articles support the use of lifestyle modifications (sleep, physical exercise, yoga), and lifestyle
intervention (counseling) in the prevention of GDM.
Conclusions: The review found that diets (Mediterranean and Dash diets), dietary supplements
(myo-inositol, probiotics, and vitamin D), lifestyle modifications (physical exercise, yoga, sleep),
and lifestyle interventions show promising results in the prevention and management of GDM.
Implications for Practice: Nurse-midwives should remain up-to-date on major interventions
and current research trends of GDM, thus safeguarding the health and safety of both pregnant
mother and her baby. The findings of this review have implications for nurse-midwives who are
working with mothers that are hesitant to use pharmaceutical therapies and prefer alternatives.
Keywords: GDM, non-pharmacological, lifestyle intervention, Mediterranean diet, exercise,
myo-inositol, vitamin D, probiotics, sleep
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Chapter I: Introduction
Gestational diabetes mellitus (GDM) is defined as glucose intolerance occurring during
pregnancy (Coustan, 2017). Due to the insulin demands of the fetus, which is highest during the
third trimester, women who are already insulin resistant are unable to increase their rate of
insulin secretion, thus resulting in higher maternal blood glucose levels. As a result, GDM
develops in women whose pancreatic functioning is insufficient to overcome the insulin
resistance associated with pregnancy (Coustan, 2017). In most cases, this insulin resistance
resolves within hours of delivering the baby, suggesting that GDM is due to the effects of
placental hormones (Fraser & Heller, 2007). However, for many women of reproductive age,
GDM can persist, potentially resulting in chronic complications. In addition, evidence shows that
women with recurrent GDM over multiple pregnancies have a 60% chance of developing Type II
diabetes mellitus later in life (Coustan, 2017).
Globally, GDM affects 15% of pregnancies, while in the United States, it affects 2–10%
of pregnancies (Carroll & Kelley, 2014). Therefore, midwives today need to be well-informed
about the effectiveness of various GDM management practices to safeguard the health of both
the pregnant mother and the baby. Early detection of GDM is necessary as it can have adverse
effects on the health of both mother and baby, both during pregnancy and chronically thereafter.
Women with glucose intolerance during pregnancy are at increased risk of long-term adverse
health outcomes, including the development of Type II diabetes mellitus, cardiovascular
diseases, and metabolic syndrome (Lindsay et al., 2015). The high maternal blood glucose is
associated with macrosomia, a condition in which the neonate’s birth weight is a significantly
heavier than usual (i.e., >4,000 g). In addition, fetal hypoglycemia (i.e., fetal plasma glucose
<30 mg/dl), stillbirths, and other morbidities during the neonatal period can also contribute to a
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high maternal blood glucose level (Carroll & Kelley, 2014). Children born to mothers with GDM
have also been shown to have an increased risk for the development of diabetes and metabolic
syndrome later in life (Bone, 2015).
During pregnancy, mothers may be hesitant to use pharmaceutical therapies and may
prefer other alternatives (Zaki & Albarraq, 2014). In a study of 760 pregnant women attending
an obstetric clinic, the majority of pregnant women (78.9%) believed that limiting the use of
medications during pregnancy was preferable for overall fetal health (Zaki & Albarraq, 2014).
Therefore, the purpose of this paper is to review research papers in order to determine whether
non-pharmacological treatments are effective in the prevention and treatment of GDM.
One of the most common non-pharmacological treatments for preventing and treating
GDM is diet. Special diets for GDM include the Dash and Mediterranean (MED) diets. The Dash
diet is a low glycemic index and low energy dense diet containing high quantities of
phytoestrogens, magnesium, potassium, and dietary fiber (Izadi et al., 2016). Similarly, the MED
diet includes the consumption of fruits, vegetables, legumes, whole grains, and foods rich in
monounsaturated fatty acids. It is also associated with lower risk for several chronic diseases,
including GDM (Izadi et al., 2016).
A second non-pharmacological treatment for prevention and treatment of GDM is dietary
supplementation with myo-inositol, vitamin D, or probiotics. Myo-inositol is a natural form of
inositol found in fruits and has been found to be helpful in glycemic control (Brown, 2016).
Vitamin D helps in the metabolism of calcium and phosphorus, and is associated with the
metabolism of glucose (Zhang et al., 2016). Probiotics are live microbial supplements that
improve the intestinal microbial balance. They have also been found to have positive effect on
metabolism, and the prevention of type II diabetes and GDM (Dolatkhah et al., 2015).
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A third non-pharmacological treatment for preventing GDM includes lifestyle
interventions, such as exercise, sleep, and counseling. Physical exercise and yoga helps to
promote blood circulation and improves insulin sensitivity, resulting in the increased utilization
of glucose by muscle cells (Sununta, Sasitorn, & Thitiporn, 2014). A yoga exercise program,
using pranayama (deep-breathing) and asanas (posture and movement) techniques, has been
developed for pregnant women with GDM (Sununta et al., 2014). Counseling is arguably one of
the more significant approaches to the management of diabetes, resulting in the empowerment of
women with the knowledge and tools needed to optimize their own health while reducing
adverse pregnancy outcomes (Mills, Palmer, & Arya, 2015). A discussion of the role of diet,
body mass index (BMI), and exercise with these patients would be helpful in facilitating the
management and treatment of patients with GDM (Mills et al., 2015).
Statement of Purpose
The purpose of this paper is to examine and identify literature pertaining to the effective
non-pharmacological management (i.e., prevention and treatment) of GDM. Specifically, this
review focuses on the use of diets (including the Dash and MED diets), dietary supplementation
(using myo-inositol, vitamin D, and probiotics), exercise (i.e., cardio, yoga), and sleep in the
management of GDM.
Evidence Demonstrating Needs
The American College of Obstetrician and Gynecologists (ACOG), International
Diabetes Federation (IDF), Canadian Diabetes Association (CDA), and the British National
Institute of Health and Care Excellence (NICE) recommend diet therapy as the first line
treatment for GDM to achieve normal blood glucose levels (Carroll & Kelley, 2014). Diet has
been shown to have a positive impact on both the prevention and treatment of mild GDM.
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Nutrition therapy is a key component of the management of GDM and influences pregnancy
outcomes in mother and child (Shi et al., 2016). Dietary supplementations (e.g., myo-inositol,
vitamin D, and probiotics) during pregnancy have also been studied as potential treatments and
preventative measures for GDM. However, a Cochrane review found insufficient evidence to
support the use of myo-inositol, vitamin D, and probiotics as treatments for GDM (Coustan,
2016).
Furthermore, the ACOG, IDF, CDA, and NICE recommend that insulin should be
considered for the management of GDM if dietary interventions prove inadequate (Carroll &
Kelley, 2014). However, many women are disinclined to use insulin due to fear of needles and
injections, an unwillingness to receive several injections a day, the burdensome cost of insulin
therapy, and fears of insulin-related hypoglycemia (Carroll & Kelley, 2014). The IDF and CDA
list metformin and glyburide as alternatives for insulin non-adherent women (i.e., those who
refuse to take insulin) and in cases where insulin might be considered unsafe (Carroll & Kelley,
2014). However, the long-term effects of these drugs on the mother and baby have not yet been
studied (Carroll & Kelley, 2014).
Informed consent is a legal and ethical requirement. It is the health care provider’s
responsibility to provide adequate information to the patient so that the patient is able to process
the information and make an appropriate decision (Ryan, 2017). Informed consent helps to
protect the patient’s right of self-determination (Ryan, 2017). Therefore, women should be
presented with all the evidence for various GDM treatment methods and have the right to choose
what method they believed to be best for their health and that of their baby.
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Significance to Nurse-Midwifery
The position statement of the American College of Nurse-Midwives (ACNM) states that
nurse-midwives are primary care providers who “are accountable for addressing the majority of
health care needs, developing sustained partnerships with patients, and practicing within the
context of family and community” (ACNM, 2012, p. 21). Moreover, “health promotion, disease
prevention, and health education” (ACNM, 2013, p. 2) is one of the hallmarks of nursemidwifery. Therefore, as a health care provider, the nurse-midwife should be aware of the risk
factors, criteria for diagnosis, prevention, and treatment of GDM.
Midwifery practice should include the routine screening and diagnosing of GDM. The
US Preventative Services Task Force (USPSTF, 2016) recommends screening pregnant women
after 24 weeks gestation for GDM. Before 24 weeks gestation, there is insufficient evidence of
the benefits and harms of screening (USPSTF, 2016).
ACOG recommends a two-step process for GDM screening and diagnosis. This two-step
process involves a one-hour glucose challenge test and a three-hour glucose tolerance test (GTT)
(Coustan, 2017). In the one-hour glucose challenge test, pregnant women are provided with a
50 g oral glucose load without regard to the time of day. If the blood glucose level is >140 mg/dl
one-hour post-ingestion, the three-hour GTT should be performed (Coustan, 2017). This GTT
involves the oral administration of a 100 g oral glucose load, following which plasma serum
glucose is measured at fasting, and at one, two and three hours post-administration. In three hour
GTT, glucose threshold concentration at fasting is 95 mg/dl, at one hour is 180 mg/dl, at two
hours is 155 mg/dl, and at three hours is 140 mg/dl. When at least two of these glucose
thresholds have been met and exceeded, the diagnosis of GDM is confirmed (Kim & Floyd,
2015).
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Furthermore, midwifery practice remains up-to-date on the latest standards of care in the
prevention and treatment of GDM, incorporating new “scientific evidence into clinical practice”
(ACNM, 2013, p. 2). This use of evidence-based practice is also one of the hallmarks of nursemidwifery. This comprehensive literature review analyzes natural therapies, such as diet (e.g.,
Dash and MED), dietary supplements (e.g., myo-inositol, vitamin D, probiotic), exercise (e.g.,
physical activity, yoga), and sleep for the prevention and treatment of GDM. This research is
also congruent with another hallmark of nurse-midwifery: “incorporation of evidence-based
complementary and alternative therapies in education and practice” (ACNM, 2013, p. 2).
Theoretical Framework
King’s theory of goal attainment (TGA) provides an appropriate theoretical framework
for the prevention and treatment of GDM. TGA focuses on the process used to guide the nursepatient relationship toward the attainment of certain life goals. This theory promotes patientfamily-centered care that encourages collaboration among health care professionals, patients, and
their families (Caceres, 2015; King, 1981). Furthermore, patient-family-centered care promotes
patient satisfaction by encouraging the patient and their family to engage in open communication
with health care providers (Leon-Demare, MacDonald, Gregory, Katz, & Halas, 2015).
King’s TGA relies on four basic assumptions. The first assumption is that goals are
attained through nurse-patient interactions. The second assumption is that both the nurse and the
patient must recognize each other, and that there must be congruence between their role
expectations and role performance. The third assumption is that the nurse uses their knowledge
and skills to set goals in collaboration with the patient and that they communicate information to
the patient. The last assumption is that the nurse is proactive in helping the patient to achieve
their preset goals (Caceres, 2015).
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King’s theory is congruent with the assessment, diagnosis, planning, implementation, and
evaluation stages of the nursing process. The assessment phase is represented by concepts of
perception, judgment, action, and reaction. In this phase, the nurse and the patient begin the
process of interacting with one another and form initial judgments about one another. These
actions and reactions are made on the basis of the perceptions and judgments, which are a
product of the thoughts that the nurse and patient have about one another’s motives, behaviors,
and goals. The diagnosis phase consists of the nurse querying the patient’s environment,
personal, and interpersonal systems (Caceres, 2015). During implementation phase, the nurse
and the patient follow their mutually agreed plan. In the evaluation phase, the nurse and patient
look to determine whether their goals have been achieved. If these goals are found not have been
achieve, the nurse and patient review that factors that might have affected the achievement of
these goals (Caceres, 2015).
King’s theory is based on the notion that the patient must always be involved in their own
care, and that all clinical decision making at every stage of care is patient-centric. Therefore,
King’s theory suggests that nurses work hand-in-hand with their patients to set and meet mutual
goals for the benefit of the patient’s good health (Leon-Demare et al., 2015).
Summary
GDM is a serious condition which, if not well maintained by controlling blood glucose
levels, can result in various complications to both the mother and her baby. Therefore, it is very
important to prevent, manage, and treat GDM. As primary health care providers, midwives
should be aware of the risk factors, diagnosis, prevention, and treatment of GDM, including the
non-pharmacological and natural therapy approaches that are increasingly being sought after by
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patients. The adoption of these natural and non-pharmacological treatments, if efficacious, may
be helpful in reversing the alarming spike in the incidence of GDM over recent years.
The following chapter will outline the methods used to explore the literature, describing
the process by which original research studies that provide evidence of non-pharmaceutical
intervention for GDM were identified. These research studies, their relative strengths and
limitations, as well as subsequent recommendations for practice are addressed in Chapter 3.
Chapter 4 provides a synthesis of the studies that answer the research question, identifies gaps in
the research literature, explores the implications of this knowledge for midwifery practice, and
offers a number of recommendations for future areas of study.
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Chapter II: Methods
The purpose of this chapter is to describe the methods used to identify research studies
for review and to inform the investigation of what non-pharmacological measures might be
effective for preventing and treating GDM. A total of 35 original research articles were identified
from a search of multiple databases as satisfying the search term parameters. Of these 35
research studies, 21 met the inclusion criteria for this literature review.
Search Strategies
The literature review incorporated studies published between 2011 and 2016. The
databases used for the search were CINAHL, CINAHL PLUS, ScienceDirect, Ovid, Google
Scholar, the Cochrane Database of Systematic Reviews, and PUBMED MEDLINE. Keywords
were searched in combination using Boolean operators. These keywords, and the number of
articles for these keywords, include: gestational diabetes mellitus (21 articles), gestational
diabetes mellitus and prevention (21 articles), vitamin D and gestational diabetes mellitus (four
articles), gestational diabetes and probiotics (two articles), diet and exercise and gestational
diabetes (three articles), yoga and gestational diabetes mellitus (one articles), lifestyle
intervention and gestational diabetes mellitus (three articles), sleep and gestational diabetes
mellitus (two articles), MED diet and diabetic diet (three articles), and myo-inositol and diabetes
(three articles).
Criteria for Inclusion and Exclusion
The articles selected for this literature review were included based on their description of
effective non-pharmacological measures for the prevention and treatment of GDM. Factors such
as the quality of the original research, strength of findings, scientific rigorousness, and the age of
the study were used as inclusion criteria. Following this criteria, only research studies published
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in the last 6 years (i.e., 2011–2016) were included. One research article from 2008 is included
due its strength of its findings.
Many of the research articles identified in the initial search as having been related to the
research topic had to be excluded because they failed to satisfy scientific rigor, presented weak
or inconclusive findings, or demonstrated poor research quality. A second search of the
databases was made using the same search string, but having relaxed the criteria for date of
publication in the hope of finding strong original research studies. Many of the articles found,
however, were simply duplicates of the studies already included, while other studies failed to
satisfy the inclusion criteria.
Summary of Selected Studies
The articles included in this review consisted of 14 randomized controlled trials (RCTs),
one quasi-experimental trial, two prospective cohort studies, two case controlled studies, one
cohort study, and one prospective observational non-interventional study. The selected studies
were performed in various countries across North America, Europe, and Asia. Preference was
given to studies performed in the US; however, due to low number of articles related to the
research question, only five of the 20 research studies included in this review were performed in
the US. The remainder of the studies were, for the most part, performed in developed countries
with similar living conditions and medical facilities as those found in the US, thus enabling the
findings of this study to be generalized to the US. Italy and China had three studies each; Finland
and Iran had two studies each; while Spain, Greece, Turkey, Thailand, and India each had one
study.
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Evaluation Criteria
The Johns Hopkins Research Evidence Appraisal Tool was used to evaluate the quality of
the selected research articles (Dearholt & Dang, 2012). The level of evidence for the 21 selected
articles was appraised on a scale ranging from I to IV on the basis of their quality. Level I studies
include experimental studies, RCTs, and systematic reviews of RCTs—with or without metaanalysis. Level I studies are regarded as the highest quality research (Dearholt & Dang, 2012).
This implies consistency among generalized results: that the sample size is sufficient for the
study design, that there are adequate controls in place, that the conclusions are definitive, and
that the subsequent recommendations are consistent.
Level II includes quasi-experimental studies and systematic reviews of multiple RCTs
and quasi-experimental studies in combination, or quasi-experimental studies only, with or
without meta-analysis (Dearholt & Dang, 2012). These research studies are considered to be
good quality, with reasonably consistent results, a sufficient sample size for the study design, and
fairly definitive conclusions that lead to reasonably consistent recommendations (Dearholt &
Dang, 2012).
Level III includes non-experimental studies and systematic reviews of multiple RCTs,
quasi-experimental, and non-experimental studies in combination, or non-experimental studies
only, with or without meta-analysis (Dearholt & Dang, 2012). These studies are considered low
quality, with poor quality evidence producing inconsistent results, the sample sizes for these
studies are often insufficient for the study design, and few definitive conclusions can be drawn
(Dearholt & Dang, 2012).
Level IV includes the opinions of respected authorities. This includes nationally
recognized expert committees and/or consensus panels based on scientific evidence. Level IV
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has three sub-categories, allowing such evidence to be graded low, good, or high quality
(Dearholt & Dang, 2012).
Summary
Various databases were used in the search process to identify research articles focuses on
non-pharmacological measures for the prevention and treatment of GDM. Factors such as the
quality of the study, strength of findings, scientific rigorousness, and the age of the study were
used to select the final 21 articles that met the inclusion criteria. The John Hopkins Research
Evidence Appraisal Tool was used to evaluate the quality and the level of evidence of the
selected research articles.
The Chapter Three will provide an analysis and discussion of the selected twenty-one
research studies. These research studies, their relative strengths and limitations, as well as
subsequent recommendations for practice are addressed in the chapter. Chapter 4 provides a
synthesis of the studies that answer the research question, identifies gaps in the research
literature, explores the implications of this knowledge for midwifery practice, and offers a
number of recommendations for future areas of study.
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Chapter III: Literature Review and Analysis
This chapter provides an analysis and discussion of the selected research studies through
the matrix method. This discussion will outline the purpose of the study, the study design, and
will provide a synthesis of the major findings. At the end of the chapter, the strengths and
weaknesses of the studies are evaluated.
Synthesis of Matrix
Twenty-one scholarly research studies used were organized in a matrix (see Appendix I).
For each study included in the matrix, the purpose of study, sample size, design, level of
measurement, results, conclusions, recommendations, and the level and quality of the study (per
the appraisal tool) have been clearly noted. Organizing the research studies in such a matrix
facilitates the assessment and synthesis of findings.
Synthesis of Major Findings
All the studies chosen for this review are concerned with non-pharmacological
preventative measures for GDM. Thirteen studies included in this review support the use of
certain diets and supplements—such as the MED diet and supplementation with myo-inositol,
probiotics, or vitamin D—in the prevention and management of GDM. The remaining eight
articles explore and support the use of lifestyle modifications—such as modifying sleep duration,
physical exercise, and yoga—in the prevention of GDM, with these interventions having been
shown to impact blood glucose regulation in GDM.
The following sub-section synthesizes the major findings in relation to diet, dietary
supplementation, and lifestyle modifications.
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Diet and Supplementation
Thirteen studies were based on diet and the use of various dietary supplements for the
prevention of GDM. These studies include MED and Dash diets, and supplementation with myoinositol, vitamin D, or probiotics.
MED and Dash diets. These diets are representative of centuries old patterns of eating
and include mostly plant-based foods. The MED diet is incorporates nutrient-dense foods,
including fruits, vegetables, legumes, nuts, and whole grains. Olive oil is the main source of fat
in the MED diet. Furthermore, the MED diet includes foods that are rich in omega-3 fatty acids
and limits the amount of red meat and other animal products (Benson, Pereira, & Boucher,
2011).
There are a number of health benefits to the MED diet, such as a reduction in the
incidence and prevention of diabetes, and global improvements in cardiovascular system health
(Benson et al., 2011). This specific diet has also been shown to have a positive effect on insulin
sensitivity as a results of having replaced saturated fats and trans fats with unsaturated fats
(Benson et al., 2011). While diet is safe during pregnancy and should provide adequate folic
acid, pregnant women are recommended to supplement their prenatal intake of vitamin B12,
either through dietary supplements or by increasing their intake of animal-based foods (e.g., red
meat, fish, eggs) while on the MED diet (Balci et al., 2014).
The Dash diet includes foods that are low in total fat, saturated fat, and cholesterol. It also
includes plenty of fruits, vegetables, and whole grains. In the Dash diet, dietary protein is sources
from low fat dairy products, fish, and nuts (Harvard, 2015). The Dash diet is high in fiber,
magnesium, potassium, and calcium, while being low in sodium. The Dash diet has many
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benefits and promotes overall health; moreover, the Dash diet is best suited for those with
hypertension and is considered safe for use during pregnancy (Harvard, 2015).
This critical review evaluated two studies that assessed the effectiveness of the MED diet
and a further two studies that assessed the effectiveness of the Dash diet for the prevention of
GDM. One of the studies exploring the effectiveness of the MED diet was evaluated as level I
evidence, while the study was level II.
In the level I case control hospital-based study by Izadi et al. (2016), two groups of
pregnant women were studied: one group with GDM (n = 200) and the other without GDM (n =
260). The study showed that the MED diet was negatively related to fasting blood glucose levels,
hemoglobin A1C, and serum triacylglycerol concentrations. Also, the total serum cholesterol
level was lower in the third tertile of the MED diet group. Participants in the highest tertile of the
MED diet group had an 80% lower risk for GDM as compared with those in the lowest tertile
(p = 0.006) with p < 0.05 being considered statistically significant. Furthermore, adherence to the
Dash diet was associated with 71% lower risk of GDM (Izadi et al., 2016).
The level II prospective observational study by Karamanos et al. (2014) employed a
sample of 1076 pregnant women and explored the relationship between the MED diet and the
incidence of GDM. The study showed that the incidence of GDM was lower in subjects with
better adherence to the MED diet (8%) as compared to those with poor adherence (12%)
(p = 0.03). The study concluded that adherence to the MED diet was associated with better
glucose tolerance, even in women without GDM (Karamanos et al., 2014).
A level I RCT by Asemi, Samimi, Tabassi, Sabihi, and Esmaillzadeh (2013) explored the
effectiveness of the Dash diet in preventing GDM in two group of pregnant women with GDM:
Dash diet group (n = 16) and control group (n = 16). The study concluded that the Dash diet had
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beneficial effects on fasting plasma glucose (FPG) and serum insulin levels in pregnant women
with GDM. In this study, the Dash diet group had a lower FPG (-7.62 mg/dl) as compared to the
control group (3.68 mg/dl) (p = 0.02). The Dash diet group also had lower serum insulin levels
(-2.62 uIU/ml) as compared to the control group (4.32 uIU/ml) (p = 0.03) (Asemi et al., 2013).
Myo-inositol supplementation. Myo-inositol is a natural form of inositol found in fruits,
vegetables, nuts, and cereal (Brown, 2016). Myo-inositol is a simple carbohydrate nutrient that
the body requires for numerous cellular functions. It is available as a dietary supplement as a
water soluble powder form or in capsule form and is safe to use during pregnancy (Brown,
2016).
Three research articles exploring the effectiveness of myo-inositol supplementation as a
non-pharmacological prophylaxis against GDM were evaluated. All three articles were evaluated
to constitute level I evidence and showed the positive effect of myo-inositol supplementation on
GDM. D’Anna et al. (2015) explored the effectiveness of myo-inositol in preventing GDM in
two groups of pregnant women with GDM: myo-inositol group (n = 110) and placebo group (n =
110). The main outcome measures for the study were the occurrence of GDM and insulin
resistance. This study used the homeostasis model assessment (HOMA) for insulin resistance, a
method for assessing insulin resistance from fasting glucose and insulin. The study showed the
rate of GDM was significantly reduced in the myo-inositol group (14%) as compared with the
control group (33.6%) (p = 0.001). Furthermore, the study found that the women who were
treated with myo-inositol showed a significantly greater reduction in HOMA (M = -1.0,
SD = 3.1) as compared with the women in the control group (M = 0.1, SD = 31.8) (p = 0.048)
(D’Anna et al., 2015).
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Corrado et al. (2011) found that fasting glucose levels, insulin, and HOMA were reduced
in both myo-inositol (n = 24) and control (n = 45) groups. The experimental group, however,
demonstrated a more significant reduction across all three dependent variables (50%) as
compared the control group (29%) (p < 0.001). Therefore, the study supports the role of myoinositol in improving the insulin resistance of patients with GDM (Corrado et al., 2011).
The third study is a two year prospective, randomized, open label, and placebo-controlled
study involving a myo-inositol group (n = 110) and placebo group (n = 110). This study showed
a significant reduction in the incidence of GDM in the myo-inositol group (6%) as compared to
the placebo control group (15.3%) (p = 0.04) (D’Anna et al., 2013).
Vitamin D supplementation. Studies show that vitamin D influences the metabolism of
calcium and phosphorus, nutrients associated with diabetes mellitus (Zhang et al., 2016). This
review evaluated three studies exploring the effectiveness of vitamin D supplementation in the
prevention of GDM. Vitamin D is a fat soluble vitamin that plays an important role in bone
metabolism and seems to have some anti-inflammatory and immune-modulating properties
(Kulie, Groff, Redmer, Hounsbell, & Schrager, 2009). Furthermore, vitamin D deficiency can
cause reduced intestinal absorption of calcium and phosphorus causing bone demineralization. In
adults, severe vitamin D deficiency can result in osteomalacia, and rickets in children (DawsonHughes, 2017). The Institute of Medicine (IOM) have set the recommended daily allowance of
vitamin D at 600 international units (IU) for all women of reproductive age, including during
pregnancy and lactation (Dawson-Hughes, 2017). Furthermore, adults who do not have regular
year round sun exposure should consume at least 600–800 IU of vitamin D daily (DawsonHughes, 2017).
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All three studies reviewed here are level I studies and demonstrate positive effects for
vitamin D on GDM. Burris et al. (2012) associate second trimester maternal plasma levels of 25hydroxy vitamin D (i.e., calcifediol) with GDM. In this study of 1314 pregnant women, 25hydroxy vitamin D levels were measured during GDM screening at 26 to 28 weeks gestation.
The study showed that second trimester vitamin D levels were inversely associated with glucose
levels (p <0.01). Therefore, low vitamin D (i.e., 25-hydroxy vitamin D) levels may be associated
with an increased risk for GDM (Burris et al., 2012).
A level I RCT by Zhang et al. (2016) also explored the effects of various doses of vitamin
D supplementation on pregnant women with GDM. In the study, 133 pregnant women with
GDM at 24–28 weeks gestation were randomized in four groups with different interventions. The
control group (n = 20) received a placebo, while the other three groups received different
amounts of vitamin D: low dose (200 IU, n = 38), medium dose (2000 IU daily for 25 days to
50000 IU in total, n = 38), and high dose (4000 IU daily and 50,000 IU every 2 weeks, n = 37).
The study found that insulin, HOMA, and total cholesterol were significantly reduced in the high
dose vitamin D supplementation group (p = 0.01). The results of this study support high dose
vitamin D supplementation for improving insulin resistance in patients with GDM (Zhang et al.,
2016).
Arnold et al. (2015) explored early pregnancy maternal vitamin D concentrations and the
risk of GDM in a case-cohort study, with one group with GDM (n = 135) and another without
GDM (n = 517). The investigators measured vitamin D levels at around 16 weeks of pregnancy
using liquid chromatography-tandem mass spectroscopy. The study found that early pregnancy
vitamin D status was inversely associated with the risk of GDM. The results showed that women
with GDM had lower levels of vitamin D (M = 27.3, SD = 8.7 ng/mL) as compared to those
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without GDM (M = 29.3, SD = 8.3 ng/mL) (p = 0.01). This study demonstrated a 14% reduction
in the incidence of GDM with a 5 ng/mL increase of vitamin D supplementation in GDM
patients. Furthermore, women with total vitamin D deficiency had a 1.97 fold increased risk for
GDM (95% CI 1.12, 3.47) (Arnold et al., 2011).
Probiotic supplementation. Probiotics are live microorganisms that play an important
role in health and disease, and are studied for their role in improving immune system functions
and for the prevention of diarrhea (Zhang, Wu, & Fei, 2016). Studies have also shown that
probiotics have glucose lowering agents that impact glucose metabolism by processing dietary
polysaccharides and indigestible human enzymes (Zhang, Wu, & Fei, 2016). Furthermore, gut
microbiota may also enhance glucose storage in adipose tissue by suppressing fasting induced
adipocyte factor gene transcription (Laitinen, Poussa, & Isolauri, 2009). Probiotics use during
pregnancy appears to be safe (Elias, Bozzo & Einarson, 2011).
This review evaluated three studies that assessed the relationship between probiotics and
GDM. A level I RCT by Laitinen et al. (2009) explored the contribution of probiotics to glucose
regulation during and after pregnancy, finding that probiotics may provide a prophylactic and
therapeutic means of managing glucose disorder. In this study, 256 women during their first
trimester were randomized into three groups to receive both a special diet and probiotics
(n = 85), diet and placebo (n = 86), and placebo only (n = 85). The study found blood glucose
concentrations were lowest in the diet/probiotics group (M = 4.45 mmol/l) as compared to the
diet/placebo (M = 4.60 mmol/l), and placebo groups (M = 4.56 mmol/l) (p = 0.025). The finding
of improved glucose tolerance in the diet and probiotic group suggests that glucose control can
be improved through dietary counseling with probiotics, even among normoglycemic
populations (Laitinen et al., 2009).
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Another level I RCT by Dolatkhah et al. (2015) assessed the effects probiotic
supplementation on glucose metabolism, finding that probiotic supplements appeared to affect
glucose metabolism and weight gain in women with GDM. In this study, 64 pregnant women
were randomized to receive either probiotic supplementation (n = 32) or placebo capsules (n =
32) along with dietary advice for eight consecutive weeks. The insulin resistance index in the
probiotic group decreased significantly (6.74%) as compared to the placebo group, which
showed an increase in insulin resistance (6.45%) (p < 0.03). The pattern of weight gain was
similar for both groups until six weeks; in the last two weeks of the study, weight gain in the
probiotic group was significantly lower (M = 0.74, SD = 0.14) as compared to the placebo group
(M = 1.22, SD = 0.11) (p = 0.01) (Dolatkhah et al., 2015).
Another RCT by Lindsay et al. (2015) did not find any effect for probiotic
supplementation on glycaemia control. In this study, the investigators randomized a sample of
149 women, providing the intervention group (n = 74) with probiotic capsules and placebo
capsules to the control group (n = 75). Post-fasting glucose levels were the same for both
intervention (M = 4.65, SD = 0.49 mMol/L) and placebo groups (M = 4.65, SD = 0.53 mMol/L)
(p = 0.373) (Lindsay et al., 2015).
Lifestyle Modification
Eight studies in this review evaluated the association between GDM and lifestyle
modification. The lifestyle modifications used for the prevention and treatment of GDM included
sleep, yoga, exercise, and other lifestyle interventions, such as a combination of diet and
exercise, and a combined counseling and education intervention for diet and exercise.
Sleep. Experimental and observational studies show evidence that both reduced and
prolonged sleep are associated with impaired glucose metabolism (Rawal, Hinkle, Zhu, Albert,
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& Zhang, 2016). This could be the result of elevated oxidative stress, increased systemic
inflammation, energy homeostasis dysregulation, or chronic activation of the hypothalamicpituitary-adrenal axis. Pregnant women are particularly vulnerable to sleep disturbances due to
hormonal changes, physical discomfort, and the anxiety of childbirth (Rawal et al., 2016).
Two studies in this review examined the effects of sleep patterns and GDM. A
prospective cohort study by Rawal et al. (2016) studied the sleep duration and napping frequency
of 2581 pregnant women in the first and second trimesters. The study found that sleep duration
in the first trimester was not associated with a change in the risk for GDM. However, in the
second trimester, the association between sleep duration and GDM differed by pre-pregnancy
obesity status (p = 0.04), with this association only being significant among non-obese women.
Furthermore, non-obese women whose sleeping duration exceeded or was less than 8–9 hours
exhibited two-fold higher risk for the development of GDM. However, the highest risk for GDM
was observed among non-obese women who slept for 5–6 hours during the second trimester
(Rawal et al., 2016).
A prospective cohort study by Twedt, Bradley, Deiseroth, Althouse, and Faco (2015)
involving a sample of 45 women diagnosed with GDM. After assessing their sleep and blood
glucose levels, the investigators found that increased sleep time was associated with lower
glucose levels, while a shorter sleep duration was associated with poor glucose control in women
with GDM. The study showed that an one hour increase in sleep resulted in a statistically
significant reduction in fasting glucose (p = 0.03), post-lunch glucose (p = 0.03), and post-dinner
glucose (p = 0.001) (Twedt et al., 2015).
Yoga. A yoga exercise program for pregnant women with GDM has been developed
using pranayama (deep-breathing techniques) and asanas (posture and movements). These
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exercises are designed for 15–20 minutes daily practice, 5 days per week for 8 weeks. Asanas
yoga for pregnant women comprises nine postures: padmasana, brahma mudra, shoulder
circling, modified parvatasana, modified gomukhasana, modified tadasana, modified
chakrasana, modified bharadvajasana, and dandasana. Each posture is to be repeated ten times
(Sununta, Sasitorn, & Thitiporn, 2014).
Sununta et al. (2014) assessed the effectiveness of mindful eating and yoga exercises in
pregnant women with GDM, finding that mindful eating and yoga exercises were effective for
promoting glycemic control. In this RCT study, a sample of 180 women with GDM were
randomized to intervention (n = 90) and control groups (n = 90). The investigators found that the
women with GDM in the intervention group had significantly lower fasting blood glucose levels
(M = 83.39, SD = 17.69 mg/dL), postprandial blood glucose levels (M = 105.67, SD =
12.93 mg/dL), and A1C levels (M = 5.23%, SD = 0.72 mg/dL) than those in the control group
(respectively: M = 85.85, SD = 17.94 mg/dL, p = 0.012; M = 112.36, SD = 13.15 mg/dL,
p = 0.001, p < 0.05; M = 5.68%, SD = 0.68, p = 0.038) (Sununta et al., 2014).
Physical exercise. Exercise helps to increase the rate of glucose intake by the skeletal
muscles and improves maternal glucose homeostasis and insulin sensitivity. Furthermore,
exercise during pregnancy is associated with better glucose tolerance (Cordero, Mottola, Vargas,
Blanco, & Barakat, 2015).
Cordero et al. (2015) assessed the effectiveness of maternal physical exercise (including
land and aquatic activities that involve both aerobic and muscular conditioning) in preventing
GDM, finding that physical inactivity was associated with an elevated risk of impaired glucose
metabolism, while physical activity was associated with improved glucose metabolism. In the
study, 257 pregnant women were randomized either to an intervention group (n = 101) with
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physical exercises or to a sedentary control group (n = 156). The study found significant
difference between the prevalence of GDM between the intervention (1%, n = 1) and control
groups (8.8%, n = 13) (p = 0.009) (Cordero et al., 2015).
Anjana et al. (2016) also assessed the relationship between physical exercise and GDM,
finding that women with GDM were significantly more sedentary (86.2%) as compared to those
without GDM (61.2%) (p < 0.001). However, post-intervention with a sample diagnosed with
GDM, there was a significant increase in physical activity (p < 0.001), a decrease in sedentary
lifestyle (p < 0.001), improved glycemic control (p < 0.001), and a reduction in adverse neonatal
outcomes (p = 0.04) (Anjana et al., 2016).
Lifestyle interventions. Lifestyle interventions focus on the prevention of GDM through
counseling and education with respect to diet and exercise, and other interventions, such as
weekly motivational visit and meetings (Koivusalo et al., 2016).
Koivusalo et al. (2016) conducted a level I multi-center study to assess whether a
moderate lifestyle intervention could prevent the onset of GDM in pregnant women at risk of
GDM. The investigators reported a reduction in the incidence of GDM by 39% in high-risk
pregnant women following the intervention. In the study, 293 women meeting the following
criteria were randomized either to intervention (n = 155) or control groups (n = 138): <20 weeks
pregnant, history of GDM, and pre-pregnancy weight ≥30 kg/m2. The intervention group
received individualized counseling on diet, physical activity, and weight control from trained
nurses, and also had one group meeting with a dietician. The control group, on the other hand,
received only standard antenatal care. GDM was diagnosed in 20 intervention group participants
(13.9%) and 27 control group participants (21.6%) (p = 0.044) (Koivusalo et al., 2016).
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Sun and Zhao (2016) performed a quasi-experimental study to assess the impact of a
lifestyle intervention on the incidence of GDM and gestational weight gain among obese and
overweight women early in the course of their pregnancy. The investigators found that early
pregnancy lifestyle intervention was helpful in decreasing the incidence of GDM. In this study,
74 women 8–12 weeks were divided between control (n = 37) and intervention groups (n = 37).
The intervention group was provided with counseling on diet, exercise, and weight gain.
Moreover, participants received weekly feedback from the research nurse. Throughout the study,
the participants were encouraged to identify the factors that helped or hindered their successful
implementation of lifestyle modification. The control group only received only usual antenatal
care. In the study, GDM was diagnosed in nine of the intervention group and 19 of the control
group. Also, chi-square testing indicated that women in the intervention group had a lower
incidence of GDM (28.1%) than the women in the control group (55.9%) (p = 0.023) (Sun &
Zhao, 2016).
Wang, Ma, and Yang (2015) examined a lifestyle intervention for the prevention of GDM
and found lifestyle interventions to be efficacious in reducing the prevalence of GDM when
implemented from the beginning of the pregnancy. In this study, 1664 pregnant women with at
least one risk factor for GDM were sampled and divided between the control group (n = 138)
that received routine antenatal care and the intervention group (n = 134) that received a
standardized two-step lifestyle intervention. The study found that the incidence of GDM in the
intervention group was lower (17.16%, n = 23) as compared to the control group (23.91%, n =
33), although this difference was not statically significant (p = 0.168). Weight gain during the
first and second trimesters for the intervention group was lower (first: M = 1.38, SD = 2.34 kg;
second: M = 5.51, SD = 2.18 kg) than the control group (respectively: M = 1.41, SD = 2.58 kg;
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M = 5.66, SD = 2.25 kg); however, there was no significant difference between the groups (first:
p = 0.905; second: p = 0.567) (Wang, Ma, & Yang, 2015).
Critique of Strengths and Weaknesses
Overall, the quality of the evidence of all 21 studies reviewed in this analysis were rated
as level I and level II, meaning that they were either of good or high quality based on the John
Hopkins Research Appraisal Tool. The reviewed studies included 14 RCTs, most of which had
large sample sizes. The purpose, sample, design, measurements, results/conclusions, and
recommendations from the research articles were all easily extracted and compiled into a matrix
(see Appendix I). That said, some of the non-RCT studies suffered from low sample sizes and
provided inconclusive evidence. Studies of lifestyle interventions, diet, and exercise have
demonstrated a positive effect for the control and prevention of GDM. Notwithstanding, further
studies are needed to support the use of dietary supplements, such as probiotics and myo-inositol,
and sleep modification for the control and prevention of GDM. Furthermore, studies related to
the effectiveness of probiotics on GDM (e.g., Lindsey et al., 2014) demonstrate conflicting
results. Lindsey et al. (2014) fails to demonstrate an effect for probiotics on the difference
between glucose metabolism and changes in blood sugar levels among a sample of pregnant
women diagnosed with GDM. Therefore, further studies are needed with larger sample sizes to
conclusively determine the effectiveness of probiotics on GDM. Although myo-inositol and
sleep have been shown to have a positive effect on the prevention and management of GDM,
further RCTs with larger sample sizes are needed to provide conclusive evidence.
Summary
Twenty-one articles were selected and appraised using the Johns Hopkins Research
Evidence Appraisal Tool (Dearholt & Dang, 2012). Thirteen studies support the use of certain
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diets (e.g., Mediterranean or Dash diets), and dietary supplements (including myo-inositol,
probiotics, and vitamin D supplementation) in the prevention and management of GDM. The
other eight articles support the use of lifestyle modifications (e.g. sleep, physical exercise, yoga),
and lifestyle intervention (e.g., counseling) in the prevention of GDM. Some studies suffered
from low sample sizes, and hence, further studies are needed with larger sample sizes to
conclusively determine the effectiveness of probiotics, myo-inositol, and sleep on GDM.
The Chapter Four will provide a synthesis of the studies that answer the research
question, identifies gaps in the research literature, explores the implications of this knowledge
for midwifery practice, and offers a number of recommendations for future areas of study.
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Chapter IV: Discussion, Implications, and Conclusions
This chapter explores the implications of non-pharmacological measures for the
prevention and treatment of GDM in nurse-midwifery practice, and offers a number of
recommendations for future research. This chapter will conclude with an attempt to integrate
King’s theory of nursing with the preventative measures found to be effective for the control of
GDM.
Literature Synthesis
The research question for this review is: “what are the non-pharmacological measures to
prevent and treat gestational diabetes mellitus”? To answer this research question, 21 scholarly
articles have been identified and appraised. Non-pharmacological interventions included for the
prevention of GDM in this review include diet (e.g., MED and Dash diet), dietary supplements
(e.g., myo-inositol, probiotics, and vitamin D), lifestyle modifications (including physical
exercise, yoga, and sleep duration), and lifestyle interventions. Most of the studies in this review
focused on interventions for GDM, with there being some overlap with respect to intervention
and prevention. These show that these interventions help not only to reduce the prevalence of
GDM, but that they help patients to maintain a healthy gestational weight.
Implications for Practice
Nurse-midwives have the opportunity and responsibility to foster maternal well-being by
being aware of interventions that are beneficial. The position statement of the ACNM states that
nurse-midwives are primary care providers who “are accountable for addressing the majority of
health care needs, developing sustained partnerships with patients, and practicing within the
context of family and community” (ACNM, 2012, p. 1). Moreover, health promotion, disease
prevention, and health education are among the hallmarks of nurse-midwifery (ACNM, 2013).
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Therefore, as health care providers, nurse-midwives should be cognizant of the best preventative
measures available for their patients.
Lifestyle interventions and GDM prevention are significantly correlated. Moderate
individualized lifestyle interventions were shown to reduce the incidence of GDM by 39% in
high-risk pregnant women (Koivusalo et al., 2015). These findings can have positive health
consequences for both pregnant mother and their child. High blood sugar levels, often observed
in patients with GDM, can lead to fetal hyperglycemia. GDM-induced hyperosmolarity is
typically treated with diuretics, thus resulting in increased urination. Consequently, sugar levels
are higher in the amniotic fluid, which in turn stimulates secretions from the amniotic membrane,
potentially leading to an excess of amniotic fluid. Furthermore, hyperglycemia stimulates fetal
insulin secretion, potentially resulting in delayed fetal lung maturity, thereby increasing the
incidence of neonatal respiratory distress syndrome (Zhang et al., 2015). This review finds that
GDM can be prevented and managed in high-risk populations by simple and easily applicable
lifestyle interventions. The findings also suggest that individualized lifestyle interventions should
be initiated in early pregnancy in high-risk women and continued throughout pregnancy
(Koivusalo et al., 2015).
Nutrition therapy is central to the treatment of diabetes and is essential for its prevention
and control (Zhang et al., 2015). Healthy diets have shown to reduce diabetes, improve
cardiovascular system and overall health (Benson et al., 2011). Moreover, healthy diets have
been shown to have a positive effect on insulin sensitivity, resulting from the replacement of
saturated and trans fats with unsaturated fats (Benson et al., 2011). Nurse-midwives should
educate women on diets that reduce hyperglycemia as a standard feature of early prenatal care.
Effective patient education given to women early in pregnancy empowers them to make healthy
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choices that not only affect their pregnancy but their life-long wellness as well as that of their
families (Bone, 2015).
Educating expectant mothers about weight gain recommendations on the basis of their
pre-pregnancy BMI would be helpful as they would know about how much weight they should
be gaining. For pregnant women whose pre-pregnancy BMI is <18.5 kg/m2, a total weight gain
of 28–40 pounds is recommended. A total weight gain of 25–35 pounds is recommended for
pregnant women whose pre-pregnancy BMI ranges 18.5–24.9 kg/m2. For pregnant women whose
pre-pregnancy BMI is >25 and <30 pounds, the recommended weight gain is 15–25 pounds.
While for those who whose pre-pregnancy BMI is ≥30 kg/m2, a weight gain in the order of 11–
20 pounds is recommended (Bone, 2015).
Recommendations for Future Research
Although diet and lifestyle modifications have shown promising results in the prevention
of GDM, RCTs with larger sample sizes are needed for more conclusive results. Furthermore,
the effectiveness of sleep and dietary supplements (e.g., myo-inositol, probiotics, and vitamin D)
in the prevention of GDM are still inconclusive.
Myo-inositol
This review found studies of myo-inositol supplementation for GDM to be helpful in the
regulation of plasma glucose levels. However, the findings were not statistically significant. In
the future, a larger, multi-ethnic RCT should be conducted to evaluate the effectiveness of myoinositol supplementation for glycemic control during pregnancy (Cordero et al., 2015; D’Anna et
al., 2013; DʼAnna et al., 2015).
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Probiotics
Studies of the effectiveness of probiotics for preventing GDM have found combined
interventions—such as diet, lifestyle changes, and dietary supplements—to be effective in
reducing the prevalence of GDM (Dolatkhah et al., 2015). Dolatkhah et al. (2015) suggests that
while probiotic studies demonstrate promising results, the investigators recommend larger scale
studies in the future. Lindsay et al. (2015) failed to demonstrate the effectiveness of probiotics in
reducing GDM. The investigators conclude that the administration of probiotic capsules to
women with abnormal glucose tolerance had no impact on glycemic control. Although probiotics
did not appear to have an effect on glycemic control during pregnancy, the results of this study
showed a subtle positive effect for cholesterol. LDL cholesterol was slightly reduced among the
pregnant women treated with probiotics as compared to the placebo control group (Lindsay et al.,
2015). However, the results relating to maternal lipids were modest and the study lacked
sufficient sample size to detect changes in these parameters following probiotic treatment
(Lindsay et al., 2015).
Vitamin D
Arnold et al. (2015) provides modest evidence for the correlation between early maternal
25-hydroxy vitamin D concentrations and the risk of GDM. One weakness in this study is the
single measurement of vitamin D, since the single measurement does not allow for time
integrated measures reflecting vitamin D status. Other indicators of the biological activity of
vitamin D, including vitamin D binding protein and enzymes related to vitamin D, were not
measured in the study. Although, this study provided modest evidence for the association
between vitamin D and GDM, the study was not conclusive due to the small sample size and
limited statistical significance. Therefore, further investigation with larger sample sizes is needed
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in the future to assess the association between GDM and vitamin D concentration (Arnold et al.,
2015). The study by Zhang et al. (2008) on the association between concentration of vitamin D
and GDM has several strengths. The study determined vitamin D concentration using plasma
collected in early pregnancy. Pregnant women normally develop GDM during the second or third
trimester. Therefore, the relationship between maternal vitamin D concentrations and GDM
provides a strong predictor of GDM. Another strength of the study was the high rate of follow up
(Zhang et al., 2008). However, a limitation of this study was the single measurement of vitamin
D concentrations. A single measurement does not provide a time integrated measure for vitamin
D status throughout the entire pregnancy (Zhang et al., 2008). Although the study showed
promising result with respect to the association between maternal vitamin D and GDM, due to its
relatively small sample size, further large scale prospective studies are needed to confirm the
result of this study (Zhang et al., 2008).
Burris et al. (2012) showed a positive relationship between maternal vitamin D
concentrations and GDM. The strengths of the study includes its large sample size, and ability to
account for dietary factors and physical activities. Some of the flaws of the study, however,
include the cross sectional design of the study and the measurement of 25-hydroxy vitamin D
levels from the same blood draw for the screening of the one hour glucose load test (Burris et al.,
2012). Although, the blood samples were collected before formal diagnosis of GDM, the onset of
glucose intolerance is likely to have predated the blood having been draw. Therefore, it is
difficult to rule out reverse causation, such as physiologic changes that result from
hyperglycemia that might lower 25-hydroxy vitamin D level (Burris et al., 2012).
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Although some dietary supplements have shown promising results in the management of
GDM, none of the studies in this review discussed the prevention of long-term glucose
intolerance or type II diabetes that may result from GDM.
Integration of King’s Nursing Theory
This findings of this review attest to the benefits of alternatives to pharmacological
interventions for the GDM. In order to successfully implement these alternatives, patients must
be actively involved in their own care. King’s TGA would help to facilitate the interaction
between the provider and the patient. This interaction would help the provider assess the patient
and learn about their expectations and goals for the intervention. It would also provide baseline
information about the patient’s expectations and interest in managing GDM in the absence of
pharmacological interventions. This interaction would also help both parties to understand each
other, and allow the provider to diagnose the patient’s environment and their personal habits,
such as diet and exercise. After diagnosis, the provider can develop dietary and exercise goals in
collaboration with the patient, these goals being mutually agreed upon by both parties, and allow
various natural interventions to be implemented in order to achieve these goal. Throughout the
pregnancy, these goals should be evaluated during each visit, and readjusted and implemented
accordingly (Caceres, 2015).
The involvement of other family members is crucial in the care of the patient and is
consistent with the promotion of the King’s theory of patient-family-centered care, encouraging
collaboration among health care professionals, the patient, and their family. If a patient at risk for
the development of GDM presents for a prenatal visit, King’s theory suggests that family
members should be involved to encourage the patient to be physically active and help with the
dietary plan. It should be mutually understood that the family member and the provider will help
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the patient to adhere to the agreed dietary plan. Patients are more likely to be satisfied with their
care and the treatment plan is more likely to be successful with the involvement of other family
members. Therefore, according to King’s TGA, the involvement of other family members in the
treatment of GDM is beneficial for the nurse-midwife, the patient, and the entire family.
The review is focused on empowering the patients by making them aware about the
various natural therapy options and alternatives to pharmacological interventions that are
available for the prevention and treatment of GDM. In order to successfully implement these
alternatives, patients are expected to be actively involved in their own care (Leon-Demare et al.,
2015). Due to King’s TGA having an emphasis on patient-family-centered care, close nursepatient relationships, and emphasis on patient self-care, this model would likely facilitate the
successful prevention and treatment of GDM through non-pharmacological therapies.
Consequently, this theory provides an ideal conceptual framework for this review.
Conclusion
This review has identified a number of efficacious non-pharmacological interventions for
the prevention and management of GDM. Using the Johns Hopkins Research Evidence
Appraisal Tool, 21 scholarly articles were analyzed to identify various non-pharmacological
interventions of significance. The review found diets, such as the MED and Dash diet; dietary
supplements, including myo-inositol, probiotics, and vitamin D; lifestyle modifications, such as
physical exercise, yoga, sleep duration; and lifestyle interventions show promising results in the
prevention and management of GDM.
Nurse-midwives are in an ideal position to foster maternal well-being and to provide
various treatment options that are beneficial for pregnant women. GDM can have adverse effects
on the health of both mother and baby, affecting 15% of pregnancies worldwide, and 2–10% of
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pregnancies in the US. Therefore, nurse-midwives should remain up-to-date on effective
interventions, as well as current research trends in relation to GDM to safeguard the health of
both the pregnant mother and her baby. Nurse-midwives should be well-informed, not only of
the interventions for GDM, but the use King’s TGA in order to implement these interventions,
thus facilitating the achievement of the goal of preventing and managing GDM. If mothers are
hesitant to use pharmaceutical therapies and prefer other alternatives, then the findings of this
review would be of use to nurse-midwives in order to recommend appropriate nonpharmacological interventions for GDM. The most important contribution of the review rests in
the identification of various natural interventions and their effectiveness in the prevention and
treatment of GDM.
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To assess
the
effectivenes
s of exercise
on blood
glucose
level and
pregnancy
outcome
among the
patients
with
gestational
diabetes
mellitus.

Sample

Design

1083 pregnant Case
women
control
included in
study.
the study
were divided
into GDM
group (n =
247), and
non-GDM
group (n =
836).

Measurement

Results/ Conclusions

Recommendation

Level &
Quality

Physical activity
questionnaire
and pedometer to
measure the
physical activity.

Women with GDM were
significantly more sedentary
compared to those without
GDM (86.2 vs. 61.2%, p =
0.001).

Level I Good

Plasma glucose
and glycated
haemoglobin
(HbA1c)
measured.

Increase in physical activity
also significantly decrease
the blood glucose levels (p =
0.001).

Further larger
randomized control
trails in other low
and middle income
countries around the
world.

Physical activities are
associated with improved
glycemic control.
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To assess
the
prevention
of
gestational
diabetes
mellitus for
the patient
at higher
risk by a
moderate
lifestyle
intervention
.
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meeting the
following
criteria were
randomized
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intervention
(n = 155) or
control groups
(n = 138):
<20 weeks
pregnant,
history of
GDM, and
pre-pregnancy
weight
≥30 kg/m2

Design

Measurement

Randomize The diagnosis of
d control
gestational
trial.
diabetes mellitus
was done on the
The
basis of 75 g, 2
interventio hr oral glucose
n group
tolerance test at
received
24-28 weeks of
individuali gestation.
zed
counseling
on diet,
physical
activity,
and weight
control
from
trained
nurses, and
also had
one group
meeting
with a
dietician.
The
control
group
received
only
standard
antenatal
care.

Results/ Conclusions
GDM was diagnosed in 20
intervention group
participants (13.9%) and 27
control group participants
(21.6%) (p = 0.044).
In intervention group, the 2
hour glucose value increased
by 0.54 mmol/L from the
baseline to second trimester
and in control group by 0.55
mmol/L.
The intervention group
increased their physical
activity and improved their
dietary quality during
pregnancy which indicates a
healthier direction. With
combined moderate physical
activity and diet, the overall
incidence of GDM was
reduced by 30%. However,
the control group participants
did not increase their
physical activity or improve
the dietary quality in
significant manner.

Recommendation

Level &
Quality

The study was only
performed on white
population.
However, it may be
reasonable to
generalize as the
study protocol was
straightforward and
can be implemented
in other ethnic
groups.

Level I High

Also, the larger
sample size is needed
to see the effect on
maternal and
neonatal outcomes.
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doi:
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To evaluate
the
effectivenes
s of Dash
and MED
diets for
preventing
gestational
diabetes.

Two groups
of pregnant
women were
studied: one
group with
GDM (n =
200) and the
other without
GDM (n =
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Design
Case
control
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study.

Measurement
Food records
were analyzed
with nutritionist
IV software
modified for
Iranian foods.
Dash score was
calculated using
Fung and MED
score was
calculated using
Trichopoulou
methods.
Tertiles of Dash
and MED dietary
pattern scores
was used.

Results/ Conclusions
MED diet is negatively
related to fasting blood
glucose levels, hemoglobin
A1C, and serum
triacylglycerol
concentrations.

Recommendation

Level &
Quality

Larger cohort studies Level I would help to
High
provide a stronger
evidence of the
impact of MED and
Dash diets on GDM.
Also, the study is
The total serum cholesterol
limited to only 3 24
level was lower in the third
hour dietary records
tertile of the MED diet group. to assess dietary
Participants in the highest
intake. A more
tertile of the MED diet group comprehensive data
had an 80% lower risk for
keeping may provide
GDM as compared with
stronger evidence.
those in the lowest tertile (p = Also, further studies
0.006).
are needed in the
countries without the
Adherence to the Dash diet
above diets to
was associated with 71%
confirm these results.
lower risk of GDM
It is indicated that adherence
to Dash and MED diets was
associated with decreased
risk of GDM.
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diabetes
mellitus.
Applied
Nursing
Research,
27(4), 227230.
doi:10.1016/j.a
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To assess
the effect of
mindfulness
eating and
yoga
exercise on
the blood
sugar levels
among
pregnant
Thai
women with
GDM.

A sample of
180 women
with GDM
were
randomized to
intervention
(n = 90) and
control groups
(n = 90).

Randomize
d
controlled
trials.

Participants in
intervention
group
participated in
two sessions of
mindfulness
eating and yoga
session in class,
and more than
80% of sessions
were practiced in
their home.

Results/ Conclusions

The women with GDM in the
intervention group had
significantly lower fasting
blood glucose levels (M =
83.39, SD = 17.69 mg/dL),
postprandial blood glucose
levels (M = 105.67, SD =
12.93 mg/dL), and A1C
levels (M = 5.23%, SD =
0.72 mg/dL) than those in the
control group (respectively:
M = 85.85,
SD = 17.94 mg/dL, p =
The
0.012; M = 112.36, SD =
measurements of 13.15 mg/dL, p = 0.001, p <
blood sugar were 0.05; M = 5.68%, SD = 0.68,
by capillary
p = 0.038)
fasting plasma
glucose, 2h
Mindfulness eating and yoga
postprandial
exercise were effective for
blood glucose
glycemic control among
and hemoglobin pregnant women with GDM.
A1c.

Recommendation

Level &
Quality

Mindfulness eating
Level I and yoga exercise
High
were prescribed to
the patient to follow
through themselves
in their home instead
of as a group
intervention study at
the research center.
Therefore, further
studies are needed to
compare the
effectiveness of
mindfulness eating
and yoga exercise on
GDM between
practicing alone at
home or in a group
setting.

54
Citation

Purpose

Sample

Design

Measurement

D'Anna, R.,
Scilipoti, A.,
Giordano, D.,
Caruso, C.,
Cannata, M.
L.,
Interdonato,
M. L., & ... Di
Benedetto, A.
(2013). myoInositol
supplementatio
n and onset of
gestational
diabetes
mellitus in
pregnant
women with a
family history
of type 2
diabetes: a
prospective,
randomized,
placebocontrolled
study.
Diabetes Care,
36(4), 854857. doi:
10.2337/dc121371

To check
the
effectivenes
s of myoinositol
supplement
ation in
reducing the
onset of
gestational
diabetes
among the
pregnant
women with
family
history of
type 2
diabetes
mellitus.

220 pregnant
Caucasian
women were
included.
n = 110 in the
intervention
group were
treated with 2
g myoinositol plus
200 mui g
folic acid
twice a day,
whereas n =
110 in the
placebo group
were only
treated with
200 mui g
folic acid
twice daily.

Prospectiv
e,
randomize
d, open
label, and
placebo
controlled
study.

The diagnosis of
diabetes was
performed with
75-g, 2-h glucose
tolerance test.
Statistical
analysis was
done with SPSS
v17. Student ttest Fisher exact
test and Pearson
X2 tests were
used for analysis.

Results/ Conclusions
The study showed a
significant reduction in the
incidence of GDM in the
myo-inositol group (6%) as
compared to the placebo
control group (15.3%) (p =
0.04).
Moreover, there was a
difference in mean birth
weight between the groups
(3111v 3273 g). 7 fetuses in
placebo group weigh > 4000
g and there were none in the
control group.
The study supports the
involvement of inositol in the
mechanisms of glycemic
control.
It also concluded that
inositolphosphogl may play a
role not only in glycemic
control, but also in the fetal
growth of GDM women.

Recommendation

Level &
Quality

Larger studies are
required to confirm
the effect of myoinositol
supplementation in
prevention of GDM.

Level I High
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Results/ Conclusions

Recommendation

Level &
Quality

Sun, Y., &
Zhao, H.
(2015). The
effectiveness
of lifestyle
intervention in
early
pregnancy to
prevent
gestational
diabetes
mellitus in
chinese
overweight
and obese
women: a
quasiexperimental
study. Applied
Nursing
Research,
30(2016). Doi:
10.1016/j.apnr.
2015.10.006

To assess
the impact
of lifestyle
intervention
in early
pregnancy
on the
reduction of
the
incidence of
GDM and
gestational
weight gain
among
Chinese
overweight
and obese
pregnant
women.

74 women 8–
12 weeks
were divided
between
control (n =
37) and
intervention
groups
(n = 37).

Quasiexperiment
al study.
Convenien
ce
sampling.

At 24-30 weeks
glucose
challenge test
was performed
on all and oral
glucose tolerance
test was
performed on
women with
glucose value >
7.8 mmol/l.

GDM was diagnosed in nine
of the intervention group and
19 of the control group. Also,
chi-square testing indicated
that women in the
intervention group had a
lower incidence of GDM
(28.1%) than the women in
the control group (55.9%) (p
= 0.023)

Further research
should be performed
with a large sample
size.

Level II
- Good

The gestational weight gain
at the end of 28 weeks was
significantly higher among
control group (10.08 kg) as
compared to intervention
group (6.86 kg) (p = 0.001).

In this research the
samples were only
recruited from a
single hospital and
not in a randomized
method.

Lifestyle intervention during
early pregnancy is effective
in decreasing the incidence of
gestational diabetes and also
decreasing the excessive
maternal weight gain at the
end of second trimester in
overweight and obese
Chinese women.

Moreover, selfreporting of pre
pregnancy weight
should be replaced
by reliable method.

GDM diagnosis
was made
according to
IADPSG criteria.
The weight gain
was calculated as
the weight
difference
between weight
at 28 weeks and
pre pregnancy.

The patients should
be recruited from
different hospital and
in randomized
method.
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Cordero, Y.,
Mottola, M. F.,
Vargas, J.,
Blanco, M., &
Barakat, R.
(2015).
Exercise is
associated
with a
reduction in
gestational
diabetes
mellitus.
Medicine &
Science In
Sports &
Exercise,
47(7), 13281333.
doi:10.1249/M
SS.000000000
0000547

To assess
the
effectivenes
s of a
maternal
exercise
program
(land/aquati
c activities,
both aerobic
and
muscular
conditionin
g) in
preventing
GDM.

Sample

Design

Measurement

257 pregnant Randomize 50 gram
women were d control
maternal glucose
randomized
trial.
screen at 24-28
either to an
week of
intervention
gestation, and
group (n =
glucose level
101) with
was determined
physical
1 hour after a 50
exercises or to
-g load of
a sedentary
glucose
control group
administration
(n = 156)
orally.
The screen test
was considered
positive when
the values are
equal or greater
than 140 mg/dl.

Results/ Conclusions
There were no differences for
the 50-g maternal glucose
screening values between the
groups. However, the glucose
values corresponding to
OGTT at 3 hours showed that
interventional group had
lower values blood sugar
level compared to control
group.
The study found significant
difference between the
prevalence of GDM between
the intervention (1%, n = 1)
and control groups (8.8%, n
= 13) (p = 0.009).

Overall, physical inactivity is
associated with the risk of
Statistical
glucose intolerance, and
analysis such as physical activity is associated
t-test, X-test, etc. with better response to
were performed glucose metabolism.
with SPSS v20.

Recommendation

Level &
Quality

There was no
Level I nutrition analysis
High
performed, in the
study. All the women
were exposed to the
same standard care
that emphasizes
healthy eating and
healthy lifestyle.
Therefore, future
studies need to have
nutritional study.
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Zhang, C.,
Qiu, C., Hu, F.
B., David, R.
M., van Dam,
R. M., Bralley,
A., &
Williams, M.
A. (2008).
Maternal
plasma 25hydroxyvitami
nD
concentrations
and the risk for
gestational
diabetes
Mellitus. PLoS
ONE, 3(11).
doi:
10.1371/journa
l.pone.000375
3

To assess
the
effectivenes
s of vitamin
D in
maintaining
glucose
homeostasis
during
gestational
diabetes.

Sample

Design

Total 953
Case
pregnant
control
women were study.
selected with
57 women,
who
developed
GDM as
intervention
group, and
114 pregnant
women
without GDM
as control.

Measurement

Results/ Conclusions

Recommendation

Level &
Quality

Pregnant women
were screened at
24-28 weeks
gestation using
50 grams 1- hour
oral glucose
challenge test.
Plasma 25-(OH)
D concentrations
were measured
using DiaSorin
immuneassay
reagents.

Pregnant women who
developed GDM had vitamin
D concentrations
significantly lower than
control (24.2 vs. 30.1 ng/ml,
p <0.001).

Further longitudinal
studies with serial
measurements of
maternal plasma 25(OH) D
concentrations are
needed.

Level I Good

The study suggest that
maternal vitamin D
deficiency in early pregnancy
is significantly associated
with an elevated risk of
GDM.

Larger sample size
and inclusion of
minority group
would give the better
result.
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Asemi, Z.,
Samimi, M.,
Tabassi, Z.,
Sabihi, S., &
Esmaillzadeh,
A. (2013). A
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controlled
clinical trial
investigating
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Dash diet on
insulin
resistance,
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stress in
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diabetes.
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29(4), 619624.
doi:10.1016/j.n
ut.2012.11.020

To
investigate
the effects
of the Dash
diet on
insulin
resistance,
serum high
sensitivity
C-reactive
protein and
biomarkers
of oxidative
stress
among
pregnant
women with
GDM.

Sample

Design

Measurement

32 pregnant
Randomize After 4 weeks of
women
d control
intervention,
diagnosed
trial.
anthropometric
with GDM at
measure,
24 to 28 week
maternal weight,
gestation were
fasting blood
randomized
sugar, serum
into Dash diet
insulin level and
group (n = 16)
insulin
and control
resistance, serum
group (n =
hs-CRP levels,
16).
and plasma total
antioxidant
capacity were
assessed.

Results/ Conclusions
In this study mean age, prepregnancy weight, and BMI
were not statistically
different between two
groups. However, the Dash
diet group had a lower FPG
(-7.62 mg/dl) as compared to
the control group
(3.68 mg/dl) (p = 0.02). The
Dash diet group also had
lower serum insulin levels (2.62 uIU/ml) as compared to
the control group
(4.32 uIU/ml) (p = 0.03)
Consumption of Dash diet in
pregnant women with GDM
had beneficial effects on
FPG, serum insulin levels,
HOMA-IR score, plasma
TAC, and total GSH levels.

Recommendation

Level &
Quality

The effects of dietary Level I pattern on pregnancy High
outcomes should be
studied further with
larger sample size in
the future studies.
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DAnna, R., Di
Benedetto, A.,
Scilipoti, A.,
Santamaria,
A.,
Interdonato,
M. L., Petrella,
E., & ...
DʼAnna, R.
(2015). Myoinositol
supplementatio
n for
prevention of
gestational
diabetes in
obese pregnant
women: A
randomized
controlled
trial.
Obstetrics &
Gynecology,
126(2).
doi:10.1097/A
OG.00000000
00000958

To evaluate
the
effectivenes
s of myoinositol
supplement
ation in
preventing
gestational
diabetes
among
obese
pregnant
women.

Sample

Design

Measurement

Two groups
Open-label Oral glucose
of pregnant
randomize tolerance test
women with
d trial.
(OGTT)
GDM: myoinositol group
(n = 110) and
placebo group
(n = 110).

Results/ Conclusions
The study showed the rate of
GDM was significantly
reduced in the myo-inositol
group (14%) as compared
with the control group
(33.6%) (p = 0.001).
Furthermore, the study found
that the women who were
treated with myo-inositol
showed a significantly
greater reduction in
homeostasis model
assessment of insulin
resistance (M = -1.0,
SD = 3.1) as compared with
the women in the control
group (M = 0.1, SD = 31.8)
(p = 0.048).
Myo-Inositol
supplementation, started in
the first trimester, in obese
pregnant women seems to
reduce the incidence in GDM
through a reduction of insulin
resistance.

Recommendation

Level &
Quality

Future studies with
randomized control
trial and larger
sample size without
dropouts.

Level I Good
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Burris, H. H.,
Rifas-Shiman,
S. L.,
Kleinman, K.,
Litonjua, A.
A., Huh, S. Y.,
Rich-Edwards,
J. W., …
Gillman, M.
W. (2012).
Vitamin D
deficiency in
pregnancy and
gestational
diabetes.
American
Journal of
Obstetrics and
Gynecology,
207(3).
Doi:10.1016/j.
ajog.2012.05.0
22

To assess
the
association
between
second
trimester
maternal
plasma
vitamin D
level and
gestational
diabetes.

Sample

Design

1314 pregnant Prospectiv
women,
e cohort
participants of study.
Project Viva,
a birth cohort
study, were
included.

Measurement

Results/ Conclusions

Recommendation

Level &
Quality

At 26-28 weeks
gestation
Vitamin D,
vitamin D2 and
vitamin D3
levels were
measured of all
pregnant women.

68 women met the criteria for
GDM. The study showed that
second trimester vitamin D
levels were inversely
associated with glucose
levels (p <0.01).

Further studies with
randomized control
trials will be needed
to further support
that vitamin D
supplementation
affects GDM risk.

Level II
- Good

GDM clinical
data were
recorded via 1
hour GTT, and if
patient fails 1
hour, 3 hour
GTT was
performed.

Low 25 (OH) D level may be
associated with increased risk
of GDM.
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Laitinen, K.,
Poussa, T., &
Isolauri, E.
(2009).
Probiotics and
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counselling
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glucose
regulation
during and
after
pregnancy: a
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trial. British
Journal Of
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101(11), 16791687.
doi:10.1017/S
000711450811
1461

To examine
the
association
between
probiotic
supplement
ation in
glucose
metabolism
in
normoglyce
miac
pregnant
women.

Sample

Design

Measurement

256 women
Randomize Plasma glucose
during their
d control
concentration
first trimester trial.
was measured
were
and blood
randomized
glycated Hb
into three
A1C, and serum
groups to
insulin
receive both a
concentration
special diet
were measured
and probiotics
among all
(n = 85), diet
participants.
and placebo
(n = 86), and
placebo only
(n = 85).

Results/ Conclusions
The study found blood
glucose concentrations were
lowest in the diet/probiotics
group (M = 4.45 mmol/l) as
compared to the diet/placebo
(M = 4.60 mmol/l), and
placebo groups (M = 4.56
mmol/l) (p = 0.025).
The study demonstrated that
improved blood glucose
control can be achieved by
dietary counseling with
probiotics even in
normoglycemic population.

Recommendation
None

Level &
Quality
Level I High
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(2015). Is
there a value
for probiotic
supplements in
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diabetes
mellitus? a
randomized
clinical trial.
Journal Of
Health,
Population &
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331(8).
doi:10.1186/s4
1043-0150034-9

To assess
the effect of
a probiotic
supplement
capsule on
glucose
metabolism
and weight
change in
women with
newly
diagnosed
GDM.

64 pregnant
women were
randomized to
receive either
probiotic
supplementati
on (n = 32) or
placebo
capsules (n =
32) along
with dietary
advice for
eight
consecutive
weeks.

Double
blind
placebo
controlled
randomize
d clinical
trial.

Measurement

Fating blood
sugar were
obtained from all
participants
before and after
the intervention.
Data was
analyzed using
Interventio SPSS v22.
n group
received
the
probiotic
capsule,
and control
group
received
placebo
capsules.
Similar
diets were
provided to
all subjects
in the
study.

Results/ Conclusions
The insulin resistance index
in the probiotic group
decreased significantly
(6.74%) as compared to the
placebo group, which showed
an increase in insulin
resistance (6.45%) (p < 0.03).
The pattern of weight gain
was similar for both groups
until six weeks; in the last
two weeks of the study,
weight gain in the probiotic
group was significantly lower
(M = 0.74, SD = 0.14) as
compared to the placebo
group (M = 1.22, SD = 0.11)
(p = 0.01).
Hence, probiotic supplement
affect glucose metabolism
and weight gain among
pregnant women with GDM.

Recommendation

Level &
Quality

The findings needs to Level I be confirmed in other High
settings before a
therapeutic value
could be approved.
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Corrado, F.,
D'Anna, R., Di
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Giordano, D.,
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Santamaria,
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(2011). The
effect of
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supplementatio
n on insulin
resistance in
patients with
gestational
diabetes.
Diabetic
Medicine,
28(8), 972975.
doi:10.1111/j.1
4645491.2011.032
84.x

To test that
myoinositol
supplement
ation will
improve
insulin
resistance in
patients
with
gestational
diabetes.

Sixty nine
patients with
gestational
diabetes were
randomly
assigned to
study group
that received
myo inositol
as tablet and
folic acid (n =
24) and
control group
that received
folic acid only
(n = 45) for 8
weeks.

Randomize
d,
controlled
trial with
open label.

The diagnosed
oral glucose
tolerance test
was performed at
the diagnostic
and after 8
weeks.
Homeostasis
model
assessment of
insulin resistance
and adiponectin
were assayed.
Statistical
analysis was
performed with
SPSS v17.

There were three women in
the study group and nine in
the control group who
required insulin treatment.
Fasting glucose and insulin,
and consequently
homeostasis model
assessment of insulin
resistance decreased in both
groups (50% in the study
group vs. 29% in the control
group), but the decline in the
study group was significantly
greater than that in the
control group (p = 0.0001).
Overall, myoinositol
improves insulin resistance in
patients with gestational
diabetes.

Recommendation

Level &
Quality

Further research is
Level I required with a larger High
sample and inclusion
of other races.
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& ...
McAuliffe, F.
M. (2015).
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probiotics in
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trial. American
Journal Of
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doi:10.1016/j.a
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To
investigate
the effects
of probiotic
capsule
intervention
on maternal
metabolic
parameters
and
pregnancy
outcome
among
pregnant
women with
gestational
diabetes
mellitus.

Sample

Design

Measurement

149 women
Randomize Fasting blood
with GDM
d control
sugar were
were
trial.
drawn at the
randomized in
beginning of the
to two groups
study, and 4-6
and provided
weeks after
with probiotic
starting the
capsules,
capsule for
intervention
analysis of
group (n =
glucose, insulin,
74), and
c-peptide and
placebo
lipids.
capsules,
control group
(n = 75).

Results/ Conclusions

Recommendation

Level &
Quality

Post-fasting glucose levels
were the same for both
intervention (M = 4.65, SD =
0.49 mMol/L) and placebo
groups (M = 4.65, SD = 0.53
mMol/L) (p = 0.373)

Further investigation
and research on
probiotic
supplementation is
required for
conclusive result.

Level I High.

A probiotic capsule
intervention among women
with abnormal glucose
tolerance had no impact on
glycemic control.
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OG.00000000
00000959

Purpose

Sample

To assess
45 women
the
diagnosed
relationship with GDM
between
sleep
duration
and glucose
control in
GDM
patients.

Design

Measurement

Results/ Conclusions

Prospectiv
e cohort
study.

Participants were
asked to follow
recommended
diet and measure
their fasting and
1- hour
postprandial
glucose values
for 1 week.
Also,
participants wore
an actigraph to
objectively
assess sleep and
completed a
sleep diary for 7
days
immediately
after their GDM
education class.

The study showed that an one
hour increase in sleep
resulted in a statistically
significant reduction in
fasting glucose (p = 0.03),
post-lunch glucose (p =
0.03), and post-dinner
glucose (p = 0.001).
It was found that short sleep
durations are associated with
worsened glucose control in
women with gestational
diabetes. Educating women
on healthy sleep and
screening sleep disorder may
have a role in optimizing
blood glucose in GDM.

Recommendation

Level &
Quality

Further studies with Level II
larger sample size to - Good
study the relationship
between the duration
of sleep and glucose
control in GDM
patient.
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Enquobahrie,
D. A., Qiu, C.,
Huang, J.,
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VanderStoep,
A., &
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A. (2015).
Early
pregnancy
maternal
vitamin D
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and risk of
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Paediatric &
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29(3), 200210.
doi:10.1111/pp
e.12182

To examine
associations
of vitamin
D with
gestational
diabetes
mellitus.

Control group
with GDM (n
= 135) and an
intervention
group without
GDM (n =
517)

Prospectiv
e nested
casecohort
study.

During early
pregnancy (16
weeks) vitamin
D concentrations
were measured
in maternal
serum using
liquid
chromatographytandem mass
spectroscopy.
GDM was
diagnosed
according to the
American
Diabetes
Association
guidelines.

The study showed that
women with GDM had lower
levels of vitamin D (M =
27.3, SD = 8.7 ng/mL) as
compared to those without
GDM (M = 29.3, SD =
8.3 ng/mL) (p = 0.01). This
study demonstrated a 14%
reduction in the incidence of
GDM with a 5 ng/mL
increase of vitamin D
supplementation in GDM
patients. Furthermore,
women with total vitamin D
deficiency had a 1.97 fold
increased risk for GDM (95%
CI 1.12, 3.47)
Early pregnancy vitamin D
status, particularly vitamin
D3, is inversely associated
with GDM risk.

Recommendation

Level &
Quality

Additional studies
are needed to better
understand the
association between
maternal vitamin D
deficiency and
GDM.

Level I High
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10.1016/j.ajog.
2016.11.1051

To examine
the
trimesterspecific
association
between
typical
sleep
duration in
pregnancy
and
subsequent
risk of
gestational
diabetes.

2581 pregnant
women who
reported their
typical sleep
duration and
napping
frequency in
the first and
second
trimester.

The
prospectiv
e study
was
conducted
on the
Eunice
Kennedy
Shriver
National
Institute of
Child
Health and
Human
Developm
ent
Singleton
cohort
(2009
through
2013)

Diagnosis of
GDM (n
=107; 4.1%)
was based on
medical
record.

Measurement
GDM diagnosis
was abstracted
from medical
records (n =
107).

Results/ Conclusions

Sleeping duration in the
second but not first trimester
was significantly related to
risk of GDM.
Among nonobese but not
obese women, both sleeping
The diagnoses
>8 hr and <8 hr were
was based on
significantly related to risk of
either the oral
GDM: 5-6 hours sleep
glucose tolerance (relative risk 2.52%), 7 hours
test, using the
(2.01%), >10 hour (2.17%).
Carpenter and
Coustan
Significant effect
diagnostic
modification by napping
criteria or
frequency was also observed.
indications of
Positive association between
medication
reduced sleep (5-7 hr) and
treated GDM on GDM was observed among
the hospital
women who rarely napped
charge diagnosis (risk 2.48%).
(n = 12).
Overall, the study provide an
important contribution to the
understanding of the link
between sleep duration and
GDM risk.

Recommendation

Level &
Quality

Future studies that
Level I assess sleep quality
High
and include objective
measures of
nocturnal and
daytime sleep
duration are needed
to extend the
findings.
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Zhang, Q.,
Cheng, Y., He,
M., Li, T., Ma,
Z., & Cheng,
H. (2016).
Effect of
various doses
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supplementatio
n on pregnant
women with
gestational
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mellitus: A
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Experimental
and
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Medicine,
12(3), 1889–
1895. doi:
10.3892/etm.2
016.3515

To assess
the
effectivenes
s of various
doses of
vitamin D
supplement
ation on
pregnant
women with
gestational
diabetes
mellitus.

133 pregnant
women with
GDM were
randomized in
four groups:
control group
(n = 20)
received a
placebo,
while the
other three
groups
received
different
amounts of
vitamin D:
low dose
(200 IU, n =
38), medium
dose (2000 IU
daily for 25
days to
50000 IU in
total, n = 38),
and high dose
(4000 IU
daily and
50,000 IU
every 2
weeks, n =
37).

Randomize
d double
blind,
controlled
clinical
trial.

Serum 25 (OH)
D concentrations
were assayed
using a
commercial
ELISA kit.
Further, blood
sample for the
measurement of
fasting plasma
glucose (FPG),
insulin.

The study found that insulin,
HOMA, and total cholesterol
were significantly reduced in
the high dose vitamin D
supplementation group (p =
0.01).
The study supports high dose
vitamin D supplementation
for improving insulin
resistance in patients with
GDM

Recommendation
None

Level &
Quality
Level I High
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Purpose

Sample

To explore 1076 pregnant
a possible
women were
relationship studied.
between the
incidence of
GDM and
the MED
diet pattern
of eating.

Design

Measurement

Results/ Conclusions

Prospectiv
e,
observatio
nal, noninterventio
nal, and
multicenter
study
performed
in 10
centers, in
10
Mediterran
ean
countries.

An OGTT was
performed during
the 24-32 weeks
with 75 g of
glucose.

The study showed that the
incidence of GDM was lower
in subjects with better
adherence to the MED diet
(8%) as compared to those
with poor adherence (12%)
(p = 0.03).

Dietary
questionnaire
and dietary
habits were
assessed and
MED diet index
(MDI) was
computed.

Adherence to a MedDiet
pattern of eating is associated
with lower incidence of
GDM and better degree of
glucose tolerance, even in
women without GDM.

Recommendation

Level &
Quality

There were relatively Level II
small number of
- Good
population from each
country. A larger
collective analysis of
data from various
population is
necessary in future
studies.
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To examine
whether
GDM can
be
prevented
by early
trimester
lifestyle
counseling
in the highrisk
population.

1664 pregnant
women with
at least one
risk factor for
GDM were
sampled and
divided
between the
control group
(n = 138) that
received
routine
antenatal care
and the
intervention
group (n =
134) that
received a
standardized
two-step
lifestyle
intervention.

Cluster
randomize
d control
study.

Measurement
Lifestyle
interventions
such as diet,
exercise,
counseling and
measurement of
serum blood
glucose level.

Results/ Conclusions
The study found that the
incidence of GDM in the
intervention group was lower
(17.16%, n = 23) as
compared to the control
group (23.91%, n = 33),
although this difference was
not statically significant (p =
0.168). Weight gain during
the first and second
trimesters for the intervention
group was lower (first: M =
1.38, SD = 2.34 kg; second:
M = 5.51, SD = 2.18 kg) than
the control group
(respectively: M = 1.41, SD =
2.58 kg; M = 5.66, SD =
2.25 kg); however, there was
no significant difference
between the groups (first: p =
0.905; second: p = 0.567).
Although there was no
statistically significant
difference, the positive rate
of GDM could be reduced by
a certain amount of lifestyle
intervention from the
beginning of pregnancy.

Recommendation

Level &
Quality

Effective
intervention should
be explored for the
high-risk pregnant
women.

Level I High
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